Zlecenie 9098207 - Rozwój kliniczny innowacyjnego kandydata na lek w terapii...

-5 • Purity: ≥98,75% • Form: solution • Concentration: 10mg/mL • References confirming in vitro and in vivo usage of the reagents are available opak: 5mg (10mg/mL); ilość: 1Trastuzumab emtansine • CAS: 1018448-65-1 • Purity: ≥99,4% • References confirming in vitro and in vivo usage of the reagents are available opak: 1mg; ilość: 2Trastuzumab • CAS: 180288-69-1 • Purity: ≥99,8% • References confirming in vitro and in vivo usage of the reagents are available opak: 1mg; ilość: 4Trypsin (Porcine), Mass Spectrometry Grade • Affinity purified and lyophilized • Modified by methylation and TPCK treatment • Resistant to autolysis • Specific activity: >10,000U/mg protein opak: 5x20ug; ilość: 2Reaction master mix for cDNA synthesis • Concentration: 5x • Sample type: RNA • Size of final product: 10kb and less • Optimal temperature: 50°C • Reaction time: 10 minutes • Nuclease-free water included • Application: RT-qPCR opak: 50reakcji; ilość: 18mL glass, blood collection tubes • Additive: sodium citrate/ficoll • Height: 125mm • Diameter: 16mm • Centrifuging conditions: 1500 - 1800xg for 20 minutes at 18 to 25°C opak: 60 sztuk; ilość: 1